Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer
Nouf H. Alsubhi(King Abdulaziz University), Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Rachel Doherty(University of Nottingham), Arvind Arora(Himalayan Institute Hospital Trust), Paul M. Moseley(Nottingham University Hospitals NHS Trust), Peter Stephens(Royal Devon & Exeter NHS Foundation Trust), Stephen Chan(Heidelberg University), Stewart G. Martin(University of Nottingham), Tarek M.A. Abdel-Fatah(University of Nottingham), Fiona K. Middleton(Newcastle University), Ian O. Ellis(University of Nottingham), Mohammed A. Aleskandarany(Nottingham University Hospitals NHS Trust), Andrew R. Green(Nottingham Biomedical Research Centre), Nicola J. Curtin(Newcastle University)
Cited by 42
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
The Attractive Female Body Weight and Female Body Dissatisfaction in 26 Countries Across 10 World Regions: Results of the International Body Project I
|Personality and Social Psychology Bulletin|2010|718